Partnerships between state health agencies and public and private payers are critical to effective statewide efforts to improve hypertension identification and control. This white paper describes opportunities, strategies, and example partnerships identified through the ASTHO Million Hearts Learning Collaborative.
ASTHO convened a Million Hearts Advisory Roundtable to find innovative strategies for public health and primary care integration to support the Million Hearts initiative. Key recommendations from this action-oriented meeting outline possible roles for how state health agencies can support the goals of Million Hearts.
The Green County Health Department (Wisconsin) updated and revised its Adult Blood Pressure Screening Policy to guide staff on protocols for accurate blood pressure measurement and screening. The policy includes counseling, referrals, and follow-up interventions to use during community-based screenings.
This is a Collaborative Practice Agreement between a pharmacist and physician granting clinical privilege to the pharmacist in accordance with the Connecticut Pharmacy Practice Act. The purpose of this agreement is to optimize patient outcomes in the area of hypertension by integrating medication therapy management into the care of patients via a collaborative practice agreement between a pharmacist and a physician. This resource includes descriptions of the clinical activities granted to the pharmacist, clinical guidelines, and a hypertension protocol.
This document features opportunities and resources for state health departments to support health systems change and the goals of several federal and national initiatives of the Division for Heart Disease and Stroke Prevention (DHDSP), the Million Hearts® Initiative, and the CDC 6|18 Initiative.
The PLF was developed in close consultation with expert legal drafters and health policy experts in Pacific Island countries (including the U.S. Affiliated Pacific Islands), along with development partners and academic institutions. The tool was finalized in 2021, and is intended to help strengthen jurisdiction laws that regulate NCD risk factors.